期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

地西他滨的临床应用研究

Clinical progress of Decitabine
下载PDF
导出
摘要 地西他滨是天然核苷2'-脱氧胞苷酸的一种类似物。2008年进口中国用于治疗骨髓增生异常综合征(MDS),2012年9月获得欧盟批准上市,用于治疗未经治疗或复发的急性髓性白血病(AML)。本文主要综述其近年国内外的临床研究进展。 Decitabine is a nucleoside metabolic inhibitor indicated for treatment of patients with myelodysplastic syn- dromes （MDS） .In September 2012,the European Medicines Agency approved as a treatment for acute myelogenous leuke- mia.The advancement of Decitabine in current clinic researches are reviewed in this article.
作者 杨同江 陈衍成 解李丽 单衍强
机构地区 齐鲁制药〈海南〉有限公司
出处 《药学研究》 CAS 2017年第5期302-304,共3页 Journal of Pharmaceutical Research
关键词 地西他滨 抗肿瘤 临床研究 Decitabine Anticancer Clinical progress
分类号 R969.3 [医药卫生—药理学]
  • 相关文献

参考文献6

二级参考文献81

  • 1张之南,沈悌.血液病诊断及疗效标准[M].北京:科学出版社,2008.103-122,131-134,172-176.
  • 2CHESON B D, GREENBERG P L, BENNETTJ M, et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia[j]o Blood, 2006, 108(2):419-425.
  • 3KANTARJIAN H, ISSA J P, ROSENFELD C S, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study[J]. Cancer, 2006, 106(8):1794-1803.
  • 4KANTARJIAN H, OKI Y, GARCIA-MANERO G, et al. Results of a randomized study of 3 schedules of low-dose decitabine in leukemia higher- risk myelodysplastic syndrome and chronic myelomonocytic leukemia[J]. Blood, 2007, 109(1):52-57.
  • 5LUBBERT M, SUCIU S, BAILA L, et al. Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase IlI study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group[J].J C/in Oncol, 2011, 29(15):1987-1996.
  • 6WANG H, WANG X Q, XU X P, et al. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome[J]. Leukemia Res, 201 0, 34(5):598-604.
  • 7BENETATOS L, HATZIMICHAEL E, DASOUL A, et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes[J]. Leukemia Res, 2010, 34(2):148-153.
  • 8MORI N, YOSHINAGA K, TOMITA K, et al. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia[J]. Leukemia Res, 2011 35(4):51 6 - 521.
  • 9THOMAS X G, DMOSZYNSKA A, WlERZBOWSKA A, et al. Results from a randomized phase III trial of decitabine versus supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed AML[J].J C/in Oncol, 2011, 29(Suppl):Abstract 6504.
  • 10GERDS A T, DEEG H J. Transplantation for myelodysplastic syndrome in the era of hypomethylating agents[J]. Curt Opin Hematol, 2012, 19(2):71-75.

共引文献93

药学研究
2017年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部